Ultragenyx Pharmaceutical Inc. 13D and 13G filings for Solid Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-11-06 4:16 pm Purchase |
2020-10-22 | 13D | Solid Biosciences Inc. SLDB |
Ultragenyx Pharmaceutical Inc. RARE |
521,720 14.500% |
521,720 (New Position) |
Filing |